siRNA Lipid Therapeutics: Special-Populations Prescribing Summary
Clinician-focused review of siRNA lipid therapeutics (inclisiran) across special populations including renal impairment, hepatic impairment, elderly patients, and pregnancy. Dosing adjustments, monitoring, and evidence gaps.
Read clinical review